Laparoscopic adjustable gastric banding (LAGB) is considered to be a safe and effective method of weight loss and reduction of comorbidities. Our publicly funded program recognizes obesity as a chronic disease, providing extensive preoperative multidisciplinary assessment and long-term follow-up after selecting the most appropriate patients for LAGB. It is not known whether the current literature is representative of the outcomes that may be achieved in a Canadian, publicly funded system. includes various creative visual elements which attract consumers with more effectiveness advertising method. Patients who attended the Weight Wise Clinic and were selected for LAGB are identified, and a retrospective analysis over a 6-year period (2005–2010) was performed. Issues captured include weight loss at 1, 2 and 3 years, complications and operational costs of ongoing care for LAGB.